Exacerbations in cystic fibrosis: 3--Management.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18234661.
- Also identified by DOI 10.1136/thx.2006.060905.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Exacerbations of pulmonary symptoms in patients with cystic fibrosis must be recognised early and treated vigorously in order to maintain pulmonary function and relieve symptoms. The aetiology of these exacerbations is discussed, together with the options for treatment and the evidence to support treatment choices.
Medical subject headings
- Anti-Bacterial Agents
- Cystic Fibrosis
- Lung Diseases
- Pseudomonas Infections